Eric Secemsky

Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM is the Director of Vascular Intervention and an interventional cardiologist within the CardioVascular Institute at Beth Israel Deaconess Medical Center (BIDMC). He is also the Section Head of Interventional Cardiology and Vascular Research at the Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology and an Assistant Professor of Medicine at Harvard Medical School. He received his medical degree from Northwestern University's Feinberg School of Medicine as part of the combined BA/MD pathway and a Master’s of Science in Epidemiology from the Harvard School of Public Health. Dr. Secemsky completed his internal medicine training at the University of California, San Francisco (UCSF), and Cardiovascular Medicine, Interventional Cardiology, and Vascular Diagnostics and Intervention training all at Massachusetts General Hospital (MGH)/Harvard Medical School. Clinically, Dr. Secemsky splits his time attending in the cardiac catheterization lab and the inpatient and outpatient vascular medicine services. Dr. Secemsky is the primary vascular interventionalist within the BIDMC catheterization lab, where he does complex venous and arterial procedures, with a focus on peripheral artery disease.

Dr. Secemsky's research involves utilizing real-world data to perform comparative effectiveness and outcomes research, with a focus on the treatment of peripheral vascular disorders. He has particular interests in drug delivery, intravascular imaging, antithrombotic therapy and pulmonary embolism intervention. Dr. Secemsky is also involved in clinical trial design and implementation, and has served as an investigator on more than a dozen trials. Dr. Secemsky’s research program is funded by the National Institutes of Health (NIH), Harvard Medical School, extramural grants and philanthropy. Dr. Secemsky has authored more than 150 publications and has mentored numerous medical students, residents, fellows and junior faculty. He is an Associate Editor at Vascular Medicine and is on the Editorial Board at Circulation: Cardiovascular Interventions. He is also the current Chair of the PERT Consortium Research Committee, is a writing member of the 2022 ACC/AHA Guideline on the Management of Lower Extremity Peripheral Artery Disease (PAD), and is the co-director of the ACC's Scientific Sessions’ Endovascular Program, SCAI's Scientific Sessions’ Endovascular Program and SVM's Fellows/APP Course. He serves on the Board of Directors for the VIVA Foundation.